SaNOtize’s NONS Phase 2 study proves efficacy in COVID-19 treatment

By Nikita Chaurasia  | Date: 2021-03-16

SaNOtize’s NONS Phase 2 study proves efficacy in COVID-19 treatment

Vancouver-headquartered biotechnology organization, SaNOtize Research & Development Corp has announced the results of its Phase 2 trials of Nitric Oxide Nasal Spray, abbreviated as NONS, for the treatment of patients diagnosed with COVID-19.

For those uninitiated, NONS treatment is based on NO (nitric oxide), a natural nano molecule produced in the human body which exhibits anti-microbial properties and characteristics proven to have a direct effect on the Coronavirus. Moreover, the treatment is designed to kill the virus in the upper airways, barricading its incubation and entry into the lungs.

According to reliable sources, the phase 2 clinical trials indicated that SaNOtize’s NONS is an effective and safe antiviral treatment that prevents the transmission of the coronavirus, shortens its course, and significantly reduces the severity of symptoms in individuals already diagnosed.

SaNOtize has issued a press release stating that the Phase 2 clinical trials found that early treatment of COVID-19 patients with NONS substantially reduced the levels of SARS-CoV-2 coronavirus, including in individuals experiencing high viral loads. Notably, NONS is the only treatment that has proven to reduce viral loads in humans.

If sources are to be believed, the preliminary data comes from a double-blind, placebo-controlled, randomized clinical trial round conducted on 79 confirmed cases of COVID-19. Furthermore, the trials recorded an average viral log of 1.362 in the first 24 hours, which is a decline of around 95%.

This was followed by a 99% drop of the viral load within 72 hours of the commencement of the test, sources confirmed.

Gilly Regev, Co-founder, and CEO of SaNOtize, was reported saying that the biotech company will now focus on efficiently administering the vaccine among the masses and will work towards bringing an end to the ongoing pandemic as well as preventing future outbreaks of relevant viruses.

SaNOtize is currently seeking Emergency Use Authorization from regulatory authorities in Canada and the United Kingdom.

Source credits –

 https://www.businesswire.com/news/home/20210315005197/en/UK-Clinical-Trial-Confirms-SaNOtize%E2%80%99s-Breakthrough-Treatment-for-COVID-19

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Russia inches closer to debt default as U.S. pushes for license expire

Russia inches closer to debt default as U.S. pushes for license expire

By Nikita Chaurasia

The United States is reportedly pushing Russia closer to a consequential debt default by refusing to extend its license to allow bondholders to pay, as Washington looks to increase pressure following Moscow’s invasion of Ukraine. The U.S. Treas...

Zomato net loss triples to USD 46 million despite 75% jump in revenues

Zomato net loss triples to USD 46 million despite 75% jump in revenues

By Nikita Chaurasia

Indian food delivery giant Zomato Limited has reported a net loss worth USD 46 million in Q4 of FY2021-22 despite witnessing a 75% growth in revenue to USD 156 million as opposed to USD 89 million it earlier recorded during the fourth quarter of the ...

Facebook-owner Meta to share more data on political advertisements

Facebook-owner Meta to share more data on political advertisements

By Nikita Chaurasia

Facebook-parent Meta Platforms Inc has recently announced that it would provide additional data from its public ad database regarding the targeting decisions made by publishers running social and political-issue advertising. As a part of the expan...

Massachusetts finds first 2022 monkeypox case in the United States

Massachusetts finds first 2022 monkeypox case in the United States

By Nikita Chaurasia

The Massachusetts Department of Public Health has recently reported the first case of a rare infection called monkeypox in a man who recently visited Canada. According to Boston’s public department, the identified case is no threat to the pu...

Russia denies plans of blocking YouTube & cutting off from the internet

Russia denies plans of blocking YouTube & cutting off from the internet

By Nikita Chaurasia

The Digital Development Minister of Russia has reportedly stated that the country is not planning to block Google’s video streaming platform YouTube as such a move would affect its users and will therefore be avoided.  It is worth notin...